tiprankstipranks
Panbela Therapeutics announces poster presentation on ivospemin at AACR
PremiumThe FlyPanbela Therapeutics announces poster presentation on ivospemin at AACR
26d ago
Panbela Therapeutics Shifts from Nasdaq to OTCQB Market
PremiumCompany Announcements
Panbela Therapeutics Shifts from Nasdaq to OTCQB Market
27d ago
Panbela Announces Transfer to OTCQB Market
PremiumPress Releases
Panbela Announces Transfer to OTCQB Market
27d ago
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
PremiumPress ReleasesPanbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
2M ago
Panbela Therapeutics Regains Compliance with Nasdaq Standards
PremiumCompany Announcements
Panbela Therapeutics Regains Compliance with Nasdaq Standards
3M ago
Panbela Therapeutics regains compliance with Nasdaq listing standards
PremiumThe Fly
Panbela Therapeutics regains compliance with Nasdaq listing standards
3M ago
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
PremiumPress ReleasesAcceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
3M ago
Panbela Therapeutics Announces Public Offering Pricing
PremiumCompany Announcements
Panbela Therapeutics Announces Public Offering Pricing
3M ago
Panbela Therapeutics Alters Security Holder Rights
PremiumCompany Announcements
Panbela Therapeutics Alters Security Holder Rights
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100